Nic Preyat

Associate Director, Process Sciences, CMC Development - Gene Therapy at UCB

Speaker

Nic Preyat holds a PhD and post-doctoral experience in Immunobiology. His academic research focused on understanding cell and molecular mechanisms controlling the immune response, cell death pathways, inflammation and cancer. In the industry, Nic had several scientific and leadership positions within two global CDMOs, Masthercell and Catalent, developing and manufacturing cell and gene therapy products. Nic Preyat had contributed to the development of various biological products ranging from viral vectors to CART, from early development to transition for commercial manufacturing. At UCB Nic Preyat contributes to the CMC development of rAAV with the ultimate goal to treat patients with genetic disorders. Through the various positions he assumed, Nic Preyat has acquired a strong expertise in cell culture, CMC development, technology transfer, good manufacturing practices and project management.